rivastigmine, Exelon (cont.)

Pharmacy Author:
Medical Editor:

SIDE EFFECTS: The most common side effects are:

About one-half of patients who take rivastigmine develop nausea, and about one-third vomit at least once, most commonly during the first few weeks of treatment as the dose is slowly increased. Between one in five and one in four patients lose weight during rivastigmine therapy (about 7 to 10 pounds, on average). One in six patients experiences a loss of appetite. About one in fifty patients develops dizziness. Overall, 15% of patients (between one in seven and one in six) discontinue therapy due to side effects.



PREPARATIONS: Capsules: 1.5, 3, 4.5, and 6 mg. Solution: 2 mg/ml. Patch: 4.6mg/24 hours, 9.5 mg/24 hours

STORAGE: Capsules and solution should be stored at room temperature, 15 C - 30 C (59 F - 86 F).

PRESCRIBED FOR: Rivastigmine is used for the treatment of mild to moderate dementia of the Alzheimer's type or mild to moderate dementia associated with Parkinson's disease.

DOSING: Rivastigmine usually is taken twice daily with meals. Due to gastrointestinal side effects that can be seen early in therapy, rivastigmine therapy is generally started at a low dose.

Medically Reviewed by a Doctor on 5/18/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index

Health Solutions From Our Sponsors